Tools & Resources

Why AONN+ Developed the Metrics Toolkit for Oncology Navigators

AONN+ leaders explain how the team developed the metrics toolkit to better assist oncology and patient navigators in regard to patient experience, clinical outcomes, and return on investment.

The AONN+ Metrics Toolkit Helps Break Down Barriers

Oncology navigators face many challenges when it comes to collecting data, measuring success, and explaining the importance of metrics to the cancer care team.

Benefits of the AONN+ Metrics Toolkit to Oncology Navigation Programs

AONN+'s Metrics Toolkit provides practical guidance for navigation programs. Hear from AONN+ leaders on how the toolkit can help create and manage your navigation program.

Start the Conversation Around Metrics

AONN+ leaders share their tips behind beginning the conversation around implementing metrics into your oncology navigation program.

The Importance of Publishing Oncology Navigation Program Metrics

Gathering metrics that evalutate the patient experience, clinical outcomes, and return on investment help showcase the success and growth of an oncology navigation program.

Financial Toxicity Resources

Joanna Fawzy Morales, Esq., and Monica Fawzy Morales, Esq. share advice on how patients with cancer can avoid financial toxicity, as well as resources for those experiencing it.

Health Equity Resources for Oncology Navigators

Mandi-Pratt Chapman shares health equity resources for cancer care professionals.

Becoming an Empowered Navigator

As acuity rises and the responsibilities of oncology and nurse navigators become more challenging, AONN+ offers resources to build, maintain, and measure your navigation program and equip you with the tools to empower yourself as a navigator.

Conquer: the journey informed, a Valuable Resource for Oncology Navigators

Editorial board member Frank dela Rama talks about Conquer: the journey informed, the official patient magazine of AONN+.

Hematology Navigation 101

The foundational principles of oncology navigation hold true for all tumor types; however, there are some important distinctions pertaining to the navigation of hematologic malignancies.